David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 80,000 shares at $35.74 ($2.9M) on 2021-01-12, disclosed to the SEC on 2021-01-13.
Open-market sale of $2.9M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.92 | 12,835 | $448K | 15.7% |
| 2 | $34.92 | 12,835 | $448K | 15.7% |
| 3 | $35.74 | 7,074 | $253K | 8.9% |
| 4 | $35.74 | 7,074 | $253K | 8.9% |
| 5 | $36.18 | 20,091 | $727K | 25.5% |
| 6 | $36.18 | 20,091 |
| $727K |
| 25.5% |
| Total | $35.70 avg | 80,000 | $2.9M | 100% |
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |